BeStock  
Stocks › Medical Devices › CNMD

ConMed CNMD

US equityMarket cap rank #3017
$47.33 +$1.01 (+2.18%)
Pre-market · Oct 6, 7:30 am ET · After hours $47.33 0.00%
Open$46.43
Prev close$46.32
Day range$46.11 – $47.77
Volume343.3K
Market cap$1.42B
P/E (TTM)25.6
Dividend yield0.42%

CNMD Stock News

Headlines matching ConMed or the CNMD ticker, most recent first.

  • A Quick Look at Today's Ratings for ConMed(CNMD.US), With a Forecast Between $45 to $46Market news · 31 Jul 2026
  • J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $40Market news · 13 Jul 2026
  • Needham Maintains ConMed(CNMD.US) With Hold RatingMarket news · 13 Jul 2026
  • BofA Securities Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $40Market news · 18 May 2026
  • Needham Maintains ConMed(CNMD.US) With Hold Rating, Announces Target Price $35.96Market news · 30 Apr 2026
  • J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $40Market news · 30 Apr 2026
  • Piper Sandler Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $39Market news · 30 Apr 2026
  • Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Alto Neuroscience, Inc. (ANRO) and Pfizer (PFE)TipRanks · 18 Mar 2026
  • Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $42Market news · 18 Mar 2026
  • Piper Sandler Downgrades ConMed(CNMD.US) to Hold Rating, Cuts Target Price to $39Market news · 17 Mar 2026
  • Piper Sandler Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $55Market news · 29 Jan 2026
  • TR | OpenAI - 4o Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $60Market news · 12 Aug 2025
  • Piper Sandler Maintains ConMed(CNMD.US) With Buy Rating, Cuts Target Price to $68Market news · 31 Jul 2025
  • Needham Downgrades ConMed(CNMD.US) to Hold RatingMarket news · 13 Jun 2025
  • Needham Maintains ConMed(CNMD.US) With Buy Rating, Cuts Target Price to $61Market news · 2 May 2025

Discussion

No comments yet — be the first to weigh in on CNMD.

Leave a comment

Scroll to Top